Stock ScreenerStock IdeasHigh Risk, High RewardHigh Risk, High Reward StocksSpeculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!
Stock ScreenerStock IdeasHigh Risk, High Reward
Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
| Ticker | Company | Zen Rating | Growth | Market Cap | Revenue | EBITDA | Earnings | EPS | Rev. Y/Y | Rev. 5Y | Earn. Y/Y | Earn. 5Y | Earnings Date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| KALA | KALA BIO INC | $5.54M | $0.00 | -$30.62M | -$35.84M | -$5.66 | N/A | -100.00% | N/A | N/A | |||
| FBLG | FIBROBIOLOGICS INC | $20.22M | $0.00 | -$17.74M | -$18.50M | -$0.48 | N/A | N/A | N/A | N/A | |||
| CANF | CAN-FITE BIOPHARMA LTD | $3.37M | $560.00k | -$8.74M | -$8.80M | $0.00 | -16.04% | -20.34% | N/A | N/A | |||
| NRXP | NRX PHARMACEUTICALS INC | $58.16M | $242.00k | -$38.02M | -$38.06M | -$2.36 | N/A | N/A | N/A | N/A | |||
| ACET | ADICET BIO INC | $76.47M | $0.00 | -$105.29M | -$115.01M | -$1.25 | N/A | -100.00% | N/A | N/A | |||
| SGMO | SANGAMO THERAPEUTICS INC | $151.42M | $32.88M | -$101.50M | -$108.91M | -$0.45 | -37.13% | -25.91% | N/A | N/A | |||
| SKYE | SKYE BIOSCIENCE INC | $34.94M | $0.00 | -$50.55M | -$51.23M | -$1.29 | N/A | N/A | N/A | N/A | |||
| BTAI | BIOXCEL THERAPEUTICS INC | $43.96M | $752.00k | -$51.29M | -$68.21M | -$9.04 | -66.96% | N/A | N/A | N/A | |||
| PHIO | PHIO PHARMACEUTICALS CORP | $12.06M | $0.00 | -$7.95M | -$7.95M | -$2.15 | N/A | N/A | N/A | N/A | |||
| MBRX | MOLECULIN BIOTECH INC | $10.14M | $0.00 | -$41.25M | -$41.36M | -$33.40 | N/A | N/A | N/A | N/A | |||
| VNRX | VOLITIONRX LTD | $33.03M | $1.47M | -$21.14M | -$22.88M | -$0.23 | 14.48% | 197.53% | N/A | N/A | |||
| LSTA | LISATA THERAPEUTICS INC | $17.64M | $1.07M | -$19.03M | -$18.24M | -$2.13 | N/A | N/A | N/A | N/A | |||
| RCKT | ROCKET PHARMACEUTICALS INC | $366.87M | $0.00 | -$227.85M | -$240.91M | -$2.25 | N/A | N/A | N/A | N/A | |||
| NAKA | KINDLY MD INC | $175.94M | $1.98M | -$89.61M | -$90.49M | -$1.11 | -31.13% | N/A | N/A | N/A | 2026-02-13 | ||
| TVRD | TVARDI THERAPEUTICS INC | $41.37M | $4.02M | -$8.73M | -$13.95M | -$8.50 | -21.70% | -31.91% | N/A | N/A | |||
| ENLV | ENLIVEX THERAPEUTICS LTD | $22.57M | $0.00 | -$14.51M | -$12.70M | -$0.55 | N/A | N/A | N/A | N/A | |||
| PSTV | PLUS THERAPEUTICS INC | $94.00M | $5.26M | -$16.33M | -$20.58M | -$1.70 | -8.16% | 28.67% | N/A | N/A | |||
| OSTX | OS THERAPIES INC | $63.74M | $0.00 | -$18.04M | -$20.26M | -$0.82 | N/A | N/A | N/A | N/A | |||
| IMUX | IMMUNIC INC | $74.82M | $0.00 | -$102.73M | -$103.05M | -$0.83 | N/A | N/A | N/A | N/A | |||
| SLN | SILENCE THERAPEUTICS PLC | $298.22M | $26.10M | -$67.75M | -$66.59M | N/A | 27.31% | N/A | N/A | N/A | |||
| IFRX | INFLARX NV | $71.13M | $73.07k | -$46.08M | -$46.63M | -$0.70 | -60.51% | N/A | N/A | N/A | |||
| PDSB | PDS BIOTECHNOLOGY CORP | $47.71M | $0.00 | -$32.21M | -$34.88M | -$0.82 | N/A | N/A | N/A | N/A | |||
| KRRO | KORRO BIO INC | $77.50M | $7.37M | -$82.74M | -$88.42M | -$9.41 | N/A | -25.32% | N/A | N/A | |||
| ONCY | ONCOLYTICS BIOTECH INC | $102.91M | $0.00 | -$25.02M | -$25.19M | -$0.28 | N/A | N/A | N/A | N/A | |||
| AKTX | AKARI THERAPEUTICS PLC | $27.81M | $0.00 | -$16.51M | -$15.77M | $0.00 | N/A | N/A | N/A | N/A | |||
| FEMY | FEMASYS INC | $50.12M | $2.06M | -$17.01M | -$19.80M | -$0.72 | 63.53% | N/A | N/A | N/A | |||
| CING | CINGULATE INC | $30.00M | $0.00 | -$21.49M | -$22.06M | -$3.62 | N/A | N/A | N/A | N/A | |||
| ATYR | ATYR PHARMA INC | $75.94M | $190.00k | -$73.96M | -$75.12M | -$0.82 | -19.15% | -53.29% | N/A | N/A | |||
| PMN | PROMIS NEUROSCIENCES INC | $19.35M | $0.00 | -$29.28M | -$29.28M | -$18.90 | N/A | N/A | N/A | N/A | |||
| ZSPC | ZSPACE INC | $14.61M | $31.55M | -$20.08M | -$21.79M | -$135.53 | -24.20% | N/A | N/A | N/A | |||
| SNTI | SENTI BIOSCIENCES INC | $34.44M | $0.00 | -$43.38M | -$47.58M | -$3.28 | N/A | N/A | N/A | N/A | |||
| CTSO | CYTOSORBENTS CORP | $42.96M | $34.35M | -$8.52M | -$10.59M | -$0.18 | 15.09% | -1.19% | N/A | N/A | |||
| RANI | RANI THERAPEUTICS HOLDINGS INC | $162.83M | $1.20M | -$21.76M | -$28.32M | -$0.79 | N/A | N/A | N/A | N/A | |||
| AMTX | AEMETIS INC | $96.39M | $201.32M | -$46.68M | -$87.87M | -$1.56 | -30.91% | 2.23% | N/A | N/A | |||
| ZYXI | ZYNEX INC | $22.49M | $108.20M | -$64.50M | -$73.96M | -$2.43 | -44.13% | 9.52% | N/A | N/A | |||
| CYBN | CYBIN INC | $153.86M | $0.00 | -$70.85M | -$71.04M | -$3.20 | N/A | N/A | N/A | N/A | |||
| MYO | MYOMO INC | $40.36M | $41.64M | -$9.73M | -$12.02M | -$0.28 | 64.99% | 50.95% | N/A | N/A | |||
| RZLT | REZOLUTE INC | $166.91M | $0.00 | -$76.61M | -$77.18M | -$0.93 | N/A | N/A | N/A | N/A | |||
| HUMA | HUMACYTE INC | $245.33M | $1.57M | -$18.88M | -$36.97M | -$0.23 | N/A | N/A | N/A | N/A | |||
| CODX | CO-DIAGNOSTICS INC | $20.76M | $507.89k | -$32.14M | -$32.18M | -$0.99 | -93.06% | -59.66% | N/A | N/A | |||
| TNYA | TENAYA THERAPEUTICS INC | $141.53M | $0.00 | -$82.99M | -$94.26M | -$0.77 | N/A | N/A | N/A | N/A | |||
| JSPR | JASPER THERAPEUTICS INC | $49.53M | $0.00 | -$89.05M | -$91.02M | -$5.92 | N/A | N/A | N/A | N/A | |||
| TCRX | TSCAN THERAPEUTICS INC | $57.32M | $8.42M | -$136.89M | -$142.60M | -$1.12 | -10.03% | N/A | N/A | N/A | |||
| CLGN | COLLPLANT BIOTECHNOLOGIES LTD | $20.73M | $2.48M | -$11.54M | -$12.16M | -$1.02 | 280.77% | -16.28% | N/A | N/A | |||
| CABA | CABALETTA BIO INC | $227.19M | $0.00 | -$145.48M | -$158.52M | -$2.53 | N/A | N/A | N/A | N/A | |||
| MGX | METAGENOMI INC | $61.95M | $30.91M | -$79.41M | -$88.74M | -$2.40 | -43.88% | N/A | N/A | N/A |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.